American National Bank Amgen Inc Transaction History

American National Bank

$816 Million
Q3 2024

A detailed history of American National Bank transactions in Amgen Inc stock. As of the latest transaction made, American National Bank holds 31,083 shares of AMGN stock, worth $9.94 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

31,083

Previous 31,574 1.56%

Holding current value

$9.94 Million

Previous $9.87 Million 1.52%

% of portfolio

1.23%

Previous 1.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$309.38 - $337.38 $151,905 - $165,653	-491 Reduced 1.56%	31,083 $10 Million
Q2 2024 Jul 23, 2024	SELL	$262.75 - $319.31 $100,107 - $121,657	-381 Reduced 1.19%	31,574 $9.87 Million
Q1 2024 Apr 10, 2024	BUY	$268.87 - $324.56 $3.04 Million - $3.67 Million	11,297 Added 54.69%	31,955 $9.09 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $392,499 - $442,786	-1,535 Reduced 6.92%	20,658 $5.95 Million
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $1.11 Million - $1.38 Million	-5,067 Reduced 18.59%	22,193 $5.96 Million
Q2 2023 Jul 12, 2023	SELL	$214.27 - $253.37 $2.08 Million - $2.46 Million	-9,718 Reduced 26.28%	27,260 $6.05 Million
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $2.91 Million - $3.54 Million	12,880 Added 53.45%	36,978 $8.94 Million
Q4 2022 Jan 10, 2023	SELL	$229.03 - $291.01 $245,291 - $311,671	-1,071 Reduced 4.26%	24,098 $6.33 Million
Q3 2022 Oct 05, 2022	BUY	$224.46 - $253.15 $4,489 - $5,063	20 Added 0.08%	25,169 $5.67 Million
Q2 2022 Jul 11, 2022	SELL	$230.71 - $256.74 $995,282 - $1.11 Million	-4,314 Reduced 14.64%	25,149 $6.12 Million
Q1 2022 Apr 08, 2022	BUY	$219.27 - $242.57 $152,611 - $168,828	696 Added 2.42%	29,463 $7.13 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $988,433 - $1.13 Million	-4,970 Reduced 14.73%	28,767 $6.47 Million
Q3 2021 Oct 12, 2021	BUY	$212.27 - $248.7 $1.63 Million - $1.91 Million	7,674 Added 29.44%	33,737 $7.17 Million
Q2 2021 Jul 12, 2021	BUY	$233.58 - $259.14 $255,770 - $283,758	1,095 Added 4.39%	26,063 $6.35 Million
Q1 2021 Apr 09, 2021	BUY	$221.91 - $258.6 $177,528 - $206,880	800 Added 3.31%	24,968 $6.21 Million
Q4 2020 Jan 06, 2021	SELL	$216.38 - $257.67 $2.52 Million - $3 Million	-11,658 Reduced 32.54%	24,168 $5.56 Million
Q3 2020 Oct 06, 2020	BUY	$234.65 - $260.95 $3,050 - $3,392	13 Added 0.04%	35,826 $9.11 Million
Q2 2020 Jul 07, 2020	BUY	$197.81 - $242.74 $1.55 Million - $1.91 Million	7,849 Added 28.07%	35,813 $8.45 Million
Q1 2020 Apr 06, 2020	BUY	$182.24 - $241.7 $406,941 - $539,716	2,233 Added 8.68%	27,964 $5.67 Million
Q4 2019 Jan 10, 2020	BUY	$189.21 - $243.2 $294,221 - $378,176	1,555 Added 6.43%	25,731 $6.2 Million
Q3 2019 Oct 10, 2019	BUY	$174.11 - $208.62 $2,089 - $2,503	12 Added 0.05%	24,176 $4.68 Million
Q2 2019 Jul 17, 2019	SELL	$166.7 - $195.41 $130,025 - $152,419	-780 Reduced 3.13%	24,164 $4.45 Million
Q1 2019 Apr 15, 2019	SELL	$180.87 - $203.88 $210,170 - $236,908	-1,162 Reduced 4.45%	24,944 $4.74 Million
Q4 2018 Jan 11, 2019	SELL	$178.4 - $208.25 $132,551 - $154,729	-743 Reduced 2.77%	26,106 $5.08 Million
Q3 2018 Oct 04, 2018	BUY	$185.29 - $208.89 $93,386 - $105,280	504 Added 1.91%	26,849 $5.57 Million
Q2 2018 Jul 05, 2018	SELL	$166.05 - $186.51 $88,836 - $99,782	-535 Reduced 1.99%	26,345 $4.86 Million
Q1 2018 Apr 10, 2018	SELL	$169.43 - $198.0 $21,178 - $24,750	-125 Reduced 0.46%	26,880 $4.58 Million
Q4 2017 Jan 11, 2018	SELL	$168.79 - $188.59 $13,671 - $15,275	-81 Reduced 0.3%	27,005 $4.7 Million
Q3 2017 Oct 10, 2017	BUY	$167.29 - $191.0 $4.53 Million - $5.17 Million	27,086	27,086 $5.05 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American National Bank, based on Form 13F filings with the SEC.

News

Stay updated on American National Bank with notifications on news.

Account

American National Bank Amgen Inc Transaction History